Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Sabita S. Soedamah-Muthu*, Shona J. Livingstone, Valentine Charlton-Menys, D. John Betteridge, Graham A. Hitman, H. Andrew W. Neil, Weihang Bao, David A. DeMicco, Gregory M. Preston, John H. Fuller, Coen D. A. Stehouwer, Casper G. Schalkwijk, Paul N. Durrington, Helen M. Colhoun

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1494-1502
Issue number7
Publication statusPublished - Jul 2015


  • Atorvastatin
  • Cardiovascular disease
  • C-reactiveprotein
  • LDL-cholesterol
  • Statins
  • Type 2 diabetes

Cite this